McKesson also announced that Nick Loporcaro, president of McKesson’s U.S. Pharmaceutical and Specialty Solutions segment, has decided to leave McKesson to pursue other opportunities. Upon Loporcaro’s departure on August 10, the company said Tyler will lead this segment until a replacement has been named.
“Nick is a talented executive, and we know he will accomplish great things in his next chapter,” said Hammergren. “He has led McKesson Canada, McKesson Specialty Health and most recently, the combined U.S. Pharmaceutical and Specialty Health business.”
Regarding Tyler, Hammergren said: “Brian is ideally suited to lead McKesson’s global operations based on his deep industry knowledge, outstanding track record as a business leader, and his commitment to operational excellence and customer success. His broad experience as the president of multiple McKesson businesses provides him with the ideal background and perspective to help lead McKesson’s strategic initiative and drive long-term growth.”
Previously chairman of the management board of McKesson Europe, Tyler has also served as president of McKesson North American Pharmaceutical Distribution and Services, McKesson U.S. Pharmaceutical, McKesson Medical-Surgical and McKesson Specialty Health, as well as executive vice president of corporate strategy and business development.
“McKesson has outstanding products, services and solutions, and world-class talent,” said Tyler. “With these assets, the company is uniquely positioned to drive innovation across the health care supply chain that will improve value for our business partners and enable better, more cost-effective patient care. I look forward to working with our customers, manufacturing partners and McKesson’s more than 78,000 associates to deliver on that potential and accelerate McKesson’s growth.”
Tyler received his M.A. and Ph.D. from the University of Chicago, Department of Economics, and earned his B.A. in economics with high honors from the University of California Santa Cruz.